According to a Feb. 28 news release from the company, the offering is expected to generate $1.12 billion. Humana will use the notes to repay a $500 million delayed draw term loan and for general corporate purposes.
The company initiated another $1.25 billion senior note offering in November 2022, and a $750 million debt offering in March 2022.
